Elenbaas B, Spirio L, Koerner F, Fleming M D, Zimonjic D B, Donaher J L, Popescu N C, Hahn W C, Weinberg R A
Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.
Genes Dev. 2001 Jan 1;15(1):50-65. doi: 10.1101/gad.828901.
A number of genetic mutations have been identified in human breast cancers, yet the specific combinations of mutations required in concert to form breast carcinoma cells remain unknown. One approach to identifying the genetic and biochemical alterations required for this process involves the transformation of primary human mammary epithelial cells (HMECs) to carcinoma cells through the introduction of specific genes. Here we show that introduction of three genes encoding the SV40 large-T antigen, the telomerase catalytic subunit, and an H-Ras oncoprotein into primary HMECs results in cells that form tumors when transplanted subcutaneously or into the mammary glands of immunocompromised mice. The tumorigenicity of these transformed cells was dependent on the level of ras oncogene expression. Interestingly, transformation of HMECs but not two other human cell types was associated with amplifications of the c-myc oncogene, which occurred during the in vitro growth of the cells. Tumors derived from the transformed HMECs were poorly differentiated carcinomas that infiltrated through adjacent tissue. When these cells were injected subcutaneously, tumors formed in only half of the injections and with an average latency of 7.5 weeks. Mixing the epithelial tumor cells with Matrigel or primary human mammary fibroblasts substantially increased the efficiency of tumor formation and decreased the latency of tumor formation, demonstrating a significant influence of the stromal microenvironment on tumorigenicity. Thus, these observations establish an experimental system for elucidating both the genetic and cell biological requirements for the development of breast cancer.
在人类乳腺癌中已鉴定出多种基因突变,但形成乳腺癌细胞所需的特定突变组合仍不清楚。确定这一过程所需的基因和生化改变的一种方法是通过引入特定基因将原代人乳腺上皮细胞(HMEC)转化为癌细胞。在此,我们表明,将编码SV40大T抗原、端粒酶催化亚基和一种H-Ras癌蛋白的三个基因导入原代HMEC中,可产生在皮下或移植到免疫缺陷小鼠乳腺中时形成肿瘤的细胞。这些转化细胞的致瘤性取决于ras癌基因的表达水平。有趣的是,HMEC的转化而非其他两种人类细胞类型的转化与c-myc癌基因的扩增有关,这种扩增发生在细胞的体外生长过程中。源自转化HMEC的肿瘤是低分化癌,可浸润相邻组织。当将这些细胞皮下注射时,只有一半的注射形成肿瘤,平均潜伏期为7.5周。将上皮肿瘤细胞与基质胶或原代人乳腺成纤维细胞混合,可显著提高肿瘤形成效率并缩短肿瘤形成潜伏期,表明基质微环境对致瘤性有重大影响。因此,这些观察结果建立了一个用于阐明乳腺癌发生发展的遗传和细胞生物学要求的实验系统。